Literature DB >> 17306785

Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samples.

Glòria Tabarés1, Klaus Jung, Janett Reiche, Carsten Stephan, Michael Lein, Rosa Peracaula, Rafael de Llorens, Wolfgang Hoesel.   

Abstract

OBJECTIVE: The isoform pattern of free prostate-specific antigen (fPSA) from sera of patients with prostate cancer (PCa) and no evidence of prostate cancer (NPCa), cancerous and non-cancerous tissues and seminal plasma, have been compared, above all regarding the degree of sialylation, with the aim to show a better discrimination of PCa and NPCa. DESIGN AND METHODS: The samples have been immunopurified and analyzed by two dimensional gel electrophoresis and western blotting. It was investigated which patterns were obtained when looking for the fPSA and the (-5/-7)proPSA (precursor form) before and after desialylation.
RESULTS: The fPSA sialylation and the proPSA pattern in cancerous and non-cancerous prostate tissues were similar to each other and only slightly different from PCa and NPCa sera. The different fPSA isoforms observed could not be due solely to differences in the degree of sialylation, because different fPSA and (-5/-7)proPSA precursor isoforms were still present after complete desialylation.
CONCLUSIONS: Although slight differences in the fPSA and (-5/-7) proPSA glycosylation and isoform pattern were observed, they were not large enough to be considered to improve PCa diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306785     DOI: 10.1016/j.clinbiochem.2006.12.006

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

Review 1.  Carbohydrate recognition by boronolectins, small molecules, and lectins.

Authors:  Shan Jin; Yunfeng Cheng; Suazette Reid; Minyong Li; Binghe Wang
Journal:  Med Res Rev       Date:  2010-03       Impact factor: 12.944

2.  Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.

Authors:  Julius O Nyalwidhe; Lucy R Betesh; Thomas W Powers; E Ellen Jones; Krista Y White; Tanya C Burch; Jasmin Brooks; Megan T Watson; Raymond S Lance; Dean A Troyer; O John Semmes; Anand Mehta; Richard R Drake
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

3.  Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.

Authors:  Krista Y White; Lucy Rodemich; Julius O Nyalwidhe; Mary Ann Comunale; Mary Ann Clements; Raymond S Lance; Paul F Schellhammer; Anand S Mehta; O John Semmes; Richard R Drake
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

4.  Microfluidic Western blotting of low-molecular-mass proteins.

Authors:  Rachel E Gerver; Amy E Herr
Journal:  Anal Chem       Date:  2014-10-15       Impact factor: 6.986

5.  Human Serum Low Molecular Mass Prostate-specific Antigen As Biomarker.

Authors:  Sanja Goč; Miroslava Jankovič
Journal:  J Med Biochem       Date:  2017-10-28       Impact factor: 3.402

Review 6.  Glycosylation Changes in Prostate Cancer Progression.

Authors:  William Butler; Jiaoti Huang
Journal:  Front Oncol       Date:  2021-12-24       Impact factor: 6.244

7.  Characterisation of the main PSA glycoforms in aggressive prostate cancer.

Authors:  Anna Gratacós-Mulleras; Adrià Duran; Akram Asadi Shehni; Montserrat Ferrer-Batallé; Manel Ramírez; Josep Comet; Rafael de Llorens; Radka Saldova; Esther Llop; Rosa Peracaula
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.